Transcat (TRNS) to Release Quarterly Earnings on Monday

Transcat (NASDAQ:TRNSGet Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, October 28th. Analysts expect the company to announce earnings of $0.47 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Transcat (NASDAQ:TRNSGet Free Report) last released its earnings results on Monday, July 29th. The scientific and technical instruments company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.20. The business had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $69.35 million. Transcat had a net margin of 5.69% and a return on equity of 8.48%. The company’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.38 earnings per share. On average, analysts expect Transcat to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Transcat Trading Down 3.0 %

Shares of Transcat stock opened at $119.76 on Friday. Transcat has a twelve month low of $84.45 and a twelve month high of $147.12. The firm has a market capitalization of $1.09 billion, a PE ratio of 75.32 and a beta of 0.67. The firm’s 50-day moving average price is $123.81 and its 200 day moving average price is $122.26.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on TRNS. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday, July 30th. Craig Hallum lowered their target price on shares of Transcat from $150.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $151.33.

Get Our Latest Report on TRNS

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Recommended Stories

Earnings History for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.